Kalvista Pharmaceuticals Inc
NASDAQ:KALV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
|
US |
|
M
|
Metro AG
XBER:B4B
|
DE |
|
Emami Ltd
BSE:531162
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KALV's stock price target?
Not Available
KALV does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Kalvista Pharmaceuticals Inc?
Projected CAGR
107%
Over the last 12 years, the compound annual growth rate for Revenue has been 49%. The projected CAGR for the next 3 years is 107%.
What is the Gross Profit forecast for Kalvista Pharmaceuticals Inc?
Projected CAGR
109%
The compound annual growth rate for Gross Profit over the next 3 years is 109%.